Skip to content

Cerus CERS Free cash flow margin

Free cash flow margin at other companies

CorMedix logo
CorMedixCRMD
48.7%+38.8pp
Haemonetics logo
HaemoneticsHAE
19.5%+9.1pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
13.8%-0.2pp
ADMA Biologics logo
ADMA BiologicsADMA
21.2%+1.4pp
Paysign logo
PaysignPAYS
82.9%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Calculated from Cerus’s reported figures.

Based on trailing twelve months.

The official record: Cerus’s 10-Q, filed May 1, 2025, on SEC EDGAR. View the filing →

Ask your AI about Cerus's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's free cash flow margin?
Cerus (CERS) reported free cash flow margin of 3.5% in Q1 2025.
How has Cerus's free cash flow margin changed year-over-year?
Cerus's free cash flow margin increased by 117.8% year-over-year, from -19.4% to 3.5%.
What is the long-term trend for Cerus's free cash flow margin?
Over 4 years (2020 to 2024), Cerus's free cash flow margin has grown at a -42.2% compound annual growth rate (CAGR), from -38% to 4.2%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.